CHICAGO (Reuters) – An experimental blood screening test from Grail Inc showed early promise in detecting early-stage lung cancers based on free-floating DNA released by tumors, according to preliminary results released on Saturday. The findings, presented at ... More »
LOS ANGELES (Reuters) – Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer. Shares of Merck have fallen 10... More »
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – Adding Roche’s (ROG.S) immunotherapy Tecentriq to older drugs doubled the ... More »
FILE PHOTO: FILE PHOTO: Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecen... More »
Scientist Frantisek Lizal looks at a model of a functioning human lung that can be used to simulate chronic diseases and their treatments in the Brno University of Technology in Brno, Czech Republic, November 22, 2016. Picture taken November 22, 2016. REUTERS/... More »
